Your Connection To Global Investors
Seoul VC Connect helps Seoul-based startups and SMEs craft more effective global fundraising strategies.
About the Program
Operated by Seoul Metropolitan Government and G3 Partners, Seoul VC Connect is committed to supporting the international fundraising goals of Seoul-based technology startups and SMEs.
We provide promising bio, medical, health and ICT startups with wide-ranging support, helping them perfect global-focused investment decks, craft winning global investment strategies and connecting them with international investors.
Recruits promising companies that are interested in raising investment from overseas sources, including traditional investors (VCs), Accelerators, Corporate Venture Capital (CVC)
Develops a global investor pitch deck (pitch script & slide deck) in English, based on close collaboration with startups’ teams
Provides 1-1 coaching and other support to prepare companies for international fundraising success and help you develop an international fundraising strategy
We’d love to tell you more about the services Seoul-VC-Connect offers.
(May 2020 – December 2020)
In Batch 1, some 15 biotech startups attended Digital BIO, the USA’s premier biotech event, held online in June 2020.
AIDOT has an AI diagnostic solution that makes cervical cancer screening faster, easier and more accurate.
AITRICS developed an AI-powered in-patient sepsis risk and alarm for hospitals.
Brilliant & Co.
Brilliant & Co. created portable air quality sensors with apps that track environmental air quality data.
CurioChips is a next-generation organ-on-a-chip company that develops in-vitro 3D cell culture architectures.
Gene Medicine develops oncolytic cancer therapies to overcome the limitations of existing treatments.
Genealogy uses AI to improve the quality of DNA test results without any in-person appointments or invasive tests.
HaimBio has developed a metabolism-based cancer therapy that kills cancer cells by starving them of energy.
KaiPharm uses AI and Big Data to improve drug discovery processes, improving assessment of drug candidates.
Medipixel has created a number of novel solutions that use Artificial Intelligence to assist intervention surgeons.
MX Bio developed a suite of three complementary solutions that can help prevent and cure periodontal disease.
Nu Eyne has developed a product that treats dry eye syndrome with electroceutical technology.
Plcoskin has developed a scaffold that makes breast reconstruction surgery procedures safer and cheaper.
StemLab transforms soma cells into stem cells to regenerate central nervous system tissues.
ViroCure develops more effective cancer therapeutics and vaccine development with oncolytic virotherapy.
YBSOFT has developed a solution that stops wheelchairs from rolling away when sitting down or standing up.
(July 2020 – December 2020)
In Batch 2, 10 IT companies are taking part in Techcrunch Disrupt 2020 and GSMA Thrive.
Follow Our Updates & Annnouncements
Don’t miss the latest news and developments at Seoul-VC-Connect.
HAVE A QUESTION TO US?